海洋环境中的重金属及其对海洋生物的影响

综述了在海洋环境中重金属输入的各种途径及其重金属对海洋生物的影响,重点介绍了重金属在几种海洋生物体内的富集效应及其吸附机理,讨论了海洋重金属污染的现况,并展望了海洋重金属污染研究的前景。     

中国海大陆架沉积物超细标准物质系列研制

5个中国海大陆架沉积物标准物质的原样分别取自东海和南海,样品风干后,先经球磨制备成200目的均匀粉体,再用气流磨进一步加工成超细粒度的均匀样品.采用激光粒度仪检测了样品的粒度分布,5个样品的平均粒度均小于4 μm(约800目).采用高精度的XRF检验了样品的均匀性并以高灵敏度的ICP-AES、ICP-MS相配合确定了其最小取样量(5 mg).有12个实验室参加了合作定值研究,定值组分均为60个,其中MSCS-1,2分别有50和51个组分定为标准值,MSCS-3,4,5有52个组分定为标准值.全组分百分总和分别为99.9%, 99.9%, 100.4%, 100.1%和99.7%.     

无毒海洋防污剂研究进展

综述了无毒海洋防污剂研究进展,从防污活性、机理、特点及应用等方面着手介绍了近年来开发的几种新型无毒天然产物防污剂和人工合成防污剂,并就其发展前景进行了展望;指出开发研制无毒海洋防污剂是海洋防污技术的发展方向之一.     

海绵Phacelliafusca中含氮化合物的分离与结构鉴定

从采自中国南海西沙群岛海域的海绵Phacellia fusca Schmidt中得到4个含氮 化合物。经~1H NMR,~(13)C NMR,HMQC,HMBC,~1H-~1HCOSY,FABMS和EIMS等光谱分析 ，确证其结构分别为：N,N'-二[2-乙氧基-1（Z）-乙烯基]脲（1），2- Bromoaldisin(2),Aldisin(3)Dibromophakellin盐酸盐(4)。其中化合物1为一具有 对称结构的新脲类化合物，命名Phacelliaurea A；化合物4是首次从该海绵中分离 得到的已知胍基生物碱，首次报到了它的~(13)C NMR数据及其归属。     

船用复合材料螺旋桨研究进展

复合材料具有比强度高,阻尼性能好及可调整纤维铺层以控制结构变形等优点.复合材料应用于螺旋桨将改善螺旋桨的推进性能和振动特性.通过对国内外复合材料螺旋桨研究成果的回顾、总结和归纳,得出了传统的算法已不满足复合材料螺旋桨的设计和预报要求,复合材料螺旋桨的设计和预报算法需考虑桨叶变形引起的空间流场变化的结论.分析了可借助纤维增强材料所具有的弯扭耦合特性,调整桨叶纤维材料铺层和桨叶结构形式来提高螺旋桨推进效率的规律性.总结了复合材料螺旋桨研究中的关键技术和复合材料螺旋桨设计流程,并指出了复合材料螺旋桨未来研究的趋势.      

基于PLC的船舶电站物理仿真综合实验装置的监控设计

开发研制了船舶电站物理仿真实验装置,对其主要的工作原理,尤其是并车控制器设计部分进行简要地介绍.通过对分布式控制结构、底层数据采集和高端管理软件等方面的研究,提出利用WinCC6.0组态软件和西门子S7系列PLC对自动化电站物理仿真实验装置进行监控系统设计.仿真结果表明,系统可以正确地实时监测和记录,监测效果很好.     

Anti-Inflammatory Dysidazirine Carboxylic Acid from the Marine Cyanobacterium Caldora sp. Collected from the Reefs of Fort Lauderdale,Florida

Dysidazirine carboxylic acid (1) was isolated from the lipophilic extract of a collection of the benthic marine cyanobacterium Caldora sp. from reefs near Fort Lauderdale, Florida. The planar structure of this new compound was determined by spectroscopic methods and comparisons between HRMS and NMR data with its reported methyl ester. The absolute configuration of the single chiral center was determined by the conversion of 1 to the methyl ester and the comparison of its specific rotation data with the two known methyl ester isomers, 2 and 3. Molecular sequencing with 16S rDNA indicated that this cyanobacterium differs from Caldora penicillata (Oscillatoriales) and represents a previously undocumented and novel Caldora species. Dysidazirine (2) showed weak cytotoxicity against HCT116 colorectal cancer cells (IC₅₀ 9.1 µM), while dysidazirine carboxylic acid (1) was non-cytotoxic. Similar cell viability patterns were observed in RAW264.7 cells with dysidazirine only (2), displaying cytotoxicity at the highest concentration tested (50 µM). The non-cytotoxic dysidazirine carboxylic acid (1) demonstrated anti-inflammatory activity in RAW264.7 cells stimulated with LPS. After 24 h, 1 inhibited the production of NO by almost 50% at 50 µM, without inducing cytotoxicity. Compound 1 rapidly decreased gene expression of the pro-inflammatory gene iNOS after 3 h post-LPS treatment and in a dose-dependent manner (IC₅₀ ~1 µM); the downregulation of iNOS persisted at least until 12 h.     

Biotechnological Innovations from Ocean: Transpiring Role of Marine Drugs in Management of Chronic Disorders

Marine drugs are abundant in number, comprise of a diverse range of structures with corresponding mechanisms of action, and hold promise for the discovery of new and better treatment approaches for the management of several chronic diseases. There are huge reserves of natural marine biological compounds, as 70 percent of the Earth is covered with oceans, indicating a diversity of chemical entities on the planet. The marine ecosystems are a rich source of bioactive products and have been explored for lead drug molecules that have proven to be novel therapeutic targets. Over the last 70 years, many structurally diverse drug products and their secondary metabolites have been isolated from marine sources. The drugs obtained from marine sources have displayed an exceptional potential in the management of a wide array of diseases, ranging from acute to chronic conditions. A beneficial role of marine drugs in human health has been recently proposed. The current review highlights various marine drugs and their compounds and role in the management of chronic diseases such as cancer, diabetes, neurodegenerative diseases, and cardiovascular disorders, which has led to the development of new drug treatment approaches.     

船舶轴系振动教学演示实验台架设计与实验分析

通过船舶轴系振动理论和实践特点的分析,设计和制作了船舶轴系振动教学演示实验台架.同时,在教学演示实验台架与实船之间开展了比对实验,在船舶轴系振动信号、轴系扭振频谱、横振频谱、纵振频谱等关键实验环节进行了比对分析和讨论,得出了船舶轴系振动教学演示实验台架的可用性和可比性.     

第四代管理系统在优化机舱管理中的应用(英文)

机舱被誉为船舶的心脏,为船舶提供主要动力来源.优化机舱管理将对航运效率和安全提供有效保障.结合机舱管理实际,讨论如何运用第四代管理系统的理论进行轮机管理的优化.